AstraZeneca | Boehringer Ingelheim | Chiesi Farmaceutici | GlaxoSmithKline | TEVA
To Learn More about IPAC
Membership within IPAC is open to companies who manufacture inhalation products.
To find out how to join IPAC or to obtain additional information, please contact us at (+1) 202.230.5133 or email us at
Contact Us

Name *

Email *



AstraZeneca - Boehringer Ingelheim - Chiesi Farmaceutici -

GlaxoSmithKline - Kindeva Drug Delivery (formerly 3M Drug Delivery Systems)

IPAC celebrates with the Montreal Protocol Parties on the 30th Anniversary of playing a critical role in caring for human health and the environment and their unwavering continued commitment to the planet.

IPAC-RS was formed as part of the International Pharmaceutical Aerosol Consortium (IPAC) in 1999 and established in 2001 as a separate Consortium, with the mission to enhance the quality and availability to patients of orally inhaled and nasal drug products (OINDP) through scientifically driven advancements related to development and regulation of these products.

1500 K Street, NW

Suite 1100

Washington, DC  20005